Susceptibility of Clinical Isolates of Enterobacteriaceae to BL-S640, a New Oral Cephalosporin
AUTOR(ES)
Watanakunakorn, Chatrchai
RESUMO
The in vitro activity of BL-S640, a 7-(2-aryl-2-aminoacetamido)-3-(heterocyclic-thiomethyl) cephalosporin, was evaluated against 338 clinical isolates of Enterobacteriaceae in comparison with ampicillin, cephalothin, cefazolin, and cephalexin. Against Escherichia coli, BL-S640 was as active as cefazolin and more active than ampicillin, cephalothin, and cephalexin. BL-S640 was as effective as the other cephalosporins tested and far more active than ampicillin against Klebsiella and was more active than cephalexin against Proteus mirabilis and the indole-positive Proteus. The majority of Enterobacter, Serratia, and Citrobacter were resistant to ampicillin and all the cephalosporins tested. With rare exceptions, the zone of inhibition by the BL-S640 30-μg disk was either larger or the same as the zone obtained by the cephalothin 30-μg disk in the Kirby-Bauer disk susceptibility test.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=429143Documentos Relacionados
- In Vitro Evaluation of a New Oral Cephalosporin, Cefatrizine (BL-S640)
- BL-S640, a Cephalosporin with a Broad Spectrum of Antibacterial Activity: Bioavailability and Therapeutic Properties in Rodents
- In Vitro Evaluation of BL-S640 Cephalosporin Antibiotic
- BL-S 640, a Cephalosporin with a Broad Spectrum of Antibacterial Activity: Properties In Vitro
- BL-S786 (Ceforanide), a New Parenteral Cephalosporin: In Vitro Studies
